FEBS Letters Journal Issues Research Articles in Vol. 596, No. 9
May 23, 2022
May 23, 2022
HEIDELBERG, Germany, May 23 -- FEBS Letters, a peer-reviewed journal from the Federation of European Biochemical Societies that says it brings forward developments in biochemistry and molecular biology, published research articles, including the following topics, in its Vol. 596, No. 9 edition:
Research Letters:
* The clinically relevant triple mutation in the mtND1 gene inactivates Escherichia coli complex I
* The 19S proteasome subunit Rpt5 reversibly ass . . .
Research Letters:
* The clinically relevant triple mutation in the mtND1 gene inactivates Escherichia coli complex I
* The 19S proteasome subunit Rpt5 reversibly ass . . .